(Q42183169)

18 October 2017

A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson's disease (English)

1 reference

18 October 2017

1 reference

1 reference

Jean-Michel Peyrin

7

0 references

Stéphane Hunot

object named as

Stéphane Hunot

series ordinal

8

0 references

M. Szelechowski

series ordinal

1

object named as

Szelechowski M

1 reference

18 October 2017

2

Bétourné A

1 reference

18 October 2017

3

Monnet Y

1 reference

18 October 2017

4

Ferré CA

1 reference

18 October 2017

5

Thouard A

1 reference

18 October 2017

6

Foret C

1 reference

18 October 2017

10

Gonzalez-Dunia D

1 reference

PubMed ID

25333748

18 October 2017

language of work or name

English

0 references

publication date

21 October 2014

1 reference

18 October 2017

Nature Communications

1 reference

18 October 2017

5

1 reference

18 October 2017

1

1 reference

13 September 2019

page(s)

5181

1 reference

https://scigraph.springernature.com/pub.10.1038/ncomms6181

18 October 2017

0 references

cites work

Mitochondria: dynamic organelles in disease, aging, and development

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Clinical progression in Parkinson disease and the neurobiology of axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Viral control of mitochondrial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Evasive strategies in rabies virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

A novel neuroprotective therapy for Parkinson's disease using a viral noncoding RNA that protects mitochondrial complex I activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Borna disease virus - fact and fantasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Protein X of Borna disease virus inhibits apoptosis and promotes viral persistence in the central nervous systems of newborn-infected rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Molecular and cellular biology of Borna disease virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

The X protein of borna disease virus serves essential functions in the viral multiplication cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

MAVS-mediated host cell defense is inhibited by Borna disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

MPTP, MPP+ and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Complex I and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Wallerian-like degeneration of central neurons after synchronized and geometrically registered mass axotomy in a three-compartmental microfluidic chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Synapto-protective drugs evaluation in reconstructed neuronal network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Axonal self-destruction and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Protocol for the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Neurotoxin-based models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Subthalamic GAD gene therapy in a Parkinson's disease rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Second-site mutations in Borna disease virus overexpressing viral accessory protein X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitochondria-penetrating peptides: sequence effects and model cargo transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Maximizing the therapeutic window of an antimicrobial drug by imparting mitochondrial sequestration in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Targeting mitochondria with organelle-specific compounds: strategies and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Observing the translocation of a mitochondria-penetrating peptide with solid-state NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Wallerian degeneration: an emerging axon death pathway linking injury and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Image-based screening identifies novel roles for IkappaB kinase and glycogen synthase kinase 3 in axonal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

XIAP regulates caspase activity in degenerating axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Quality control of mitochondria: protection against neurodegeneration and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitochondrial quality control: a matter of life and death for neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitochondrial dynamics in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Mitochondrial fission, fusion, and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

A study of rivastigmine liposomes for delivery into the brain through intranasal route

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Targeting post-mitochondrial effectors of apoptosis for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Borna disease virus glycoprotein is required for viral dissemination in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

7 January 2021

Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

7 January 2021

Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson’s Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

7 January 2021

Persistent, noncytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF-induced synaptogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6181

7 January 2021

Identifiers

DOI

10.1038/NCOMMS6181

1 reference

18 October 2017

0 references

1 reference

PubMed ID

25333748